Appropriate use of antimicrobial therapy for COVID-19 co-infection

Chih Cheng Lai; Wen Liang Yu

doi:10.2217/imt-2021-0134

Appropriate use of antimicrobial therapy for COVID-19 co-infection

研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審

原文	英語
頁（從 - 到）	1067-1070
頁數	4
期刊	Immunotherapy
卷	13
發行號	13
DOIs	https://doi.org/10.2217/imt-2021-0134
出版狀態	已發佈 - 9月 2021

ASJC Scopus subject areas

免疫學和過敏
免疫學
腫瘤科

存取文件

10.2217/imt-2021-0134

其它文件與鏈接

Link to publication in Scopus

引用此

@article{7badd59f8985429d8762abd790224693,

title = "Appropriate use of antimicrobial therapy for COVID-19 co-infection",

keywords = "antimicrobial agents, Aspergillus, bacteria, co-infection, COVID-19, mucormycosis, respiratory virus",

author = "Lai, {Chih Cheng} and Yu, {Wen Liang}",

year = "2021",

month = sep,

doi = "10.2217/imt-2021-0134",

language = "English",

volume = "13",

pages = "1067--1070",

journal = "Immunotherapy",

issn = "1750-743X",

publisher = "Taylor and Francis Ltd.",

number = "13",

}

TY - JOUR

T1 - Appropriate use of antimicrobial therapy for COVID-19 co-infection

AU - Lai, Chih Cheng

AU - Yu, Wen Liang

PY - 2021/9

Y1 - 2021/9

KW - antimicrobial agents

KW - Aspergillus

KW - bacteria

KW - co-infection

KW - COVID-19

KW - mucormycosis

KW - respiratory virus

UR - http://www.scopus.com/inward/record.url?scp=85112116147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85112116147&partnerID=8YFLogxK

U2 - 10.2217/imt-2021-0134

DO - 10.2217/imt-2021-0134

M3 - Review article

C2 - 34114473

AN - SCOPUS:85112116147

SN - 1750-743X

VL - 13

SP - 1067

EP - 1070

JO - Immunotherapy

JF - Immunotherapy

IS - 13

ER -